0001104659-25-047089.txt : 20250512 0001104659-25-047089.hdr.sgml : 20250512 20250512092524 ACCESSION NUMBER: 0001104659-25-047089 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250506 FILED AS OF DATE: 20250512 DATE AS OF CHANGE: 20250512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mosseri Marlio Charles CENTRAL INDEX KEY: 0001806384 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41264 FILM NUMBER: 25932906 MAIL ADDRESS: STREET 1: 27 RIPPLEVALE GROVE CITY: LONDON STATE: X0 ZIP: N1 1HS ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvectis Pharma, Inc. CENTRAL INDEX KEY: 0001875558 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 862405608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 BUSINESS PHONE: 360-837-7232 MAIL ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 4/A 1 tm2514779-1_4aseq1.xml OWNERSHIP DOCUMENT X0508 4/A 2025-05-06 2025-05-09 0 0001875558 Nuvectis Pharma, Inc. NVCT 0001806384 Mosseri Marlio Charles 27 RIPPLEVALE GROVE LONDON N1 1HS LIBYAN ARAB JAMAHIRIYA 0 0 1 0 0 Common Stock 2025-05-08 4 P 0 100 8.99 A 2909032 I By Emerald Hill Ventures SARL SPF. Common Stock 2025-05-08 4 P 0 100 8.71 A 2909132 I By Emerald Hill Ventures SARL SPF. Common Stock 2025-05-08 4 P 0 2400 8.97 A 2911532 I By Emerald Hill Ventures SARL SPF. Common Stock 2025-05-09 4 P 0 9850 8.947 A 2921382 I By Emerald Hill Ventures SARL SPF. Common Stock 2025-05-09 4 P 0 9817 8.9041 A 2931199 I By Emerald Hill Ventures SARL SPF. Common Stock 2025-05-09 4 P 0 5395 8.9760 A 2936594 I By Emerald Hill Ventures SARL SPF. Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL. The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to correct the price of securities acquired by the reporting in the reported transactions. The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to include transactions that occurred on May 9, 2025. /s/ Charles Mosseri-Marlio 2025-05-12